V. Bryan Lawlis

Director at Reform Biologics LLC

V. Bryan Lawlis

V. Bryan Lawlis

Director at Reform Biologics LLC

Overview
Career Highlights

Itero Biopharmaceuticals LLC
Aradigm Corp.
Covance Biotechnology Services, Inc.

RelSci Relationships

1193

Number of Boards

15

Birthday

1952

Age

67

Relationships
RelSci Relationships are individuals V. Bryan Lawlis likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman of the Board, President & Chief Executive Officer at Geron Corp.

Relationship likelihood: Strong

Co-Founder at Phoenix Venture Partners LLC

Relationship likelihood: Strong

Managing Partner at SV Life Sciences Advisers LLP

Relationship likelihood: Strong

President, Chief Executive Officer & Chairman at Coherus BioSciences, Inc.

Relationship likelihood: Strong

Chairman & Chief Executive Officer at pH Pharma Co., Ltd.

Relationship likelihood: Strong

Former Executive Director & Medical Affairs at Geron Corp.

Relationship likelihood: Strong

Vice President of Process Sciences at BioMarin Pharmaceutical, Inc.

Relationship likelihood: Strong

President at Sofinnova Ventures, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Sutro Biopharma, Inc.

Relationship likelihood: Strong

Chief Executive Officer & President at BioMarin Pharmaceutical, Inc.

Relationship likelihood: Strong

Paths to V. Bryan Lawlis
Potential Connections via
Relationship Science
You
V. Bryan Lawlis
Director at Reform Biologics LLC
Education
Ph.D. in Biochemistry
Class of 1979

Washington State University (WSU) is a public research university based in Pullman, in the U.S. state of Washington, in the Palouse region of the Pacific Northwest. Founded in 1890, WSU (colloquially referred to as Wazzu) is the state's original and largest land-grant university. The university is well known for its programs in chemical engineering, veterinary medicine, agriculture, animal science, food science, plant science, architecture, neuroscience and communications. It is ranked in the top-ten universities in the US in terms of clean technology and it is one of 96 public and private universities in America with "very high research activity," as determined by the Carnegie Foundation for the Advancement of Teaching. WSU is ranked among the top half of national universities at 115th according to U.S. News and World Report.

B.A. in Microbiology

The University of Texas at Austin is one of the largest public universities in the United States and is the largest institution of The University of Texas System. Founded in 1883, the university has grown from a single building, eight teachers, two departments and 221 students to a 350-acre main campus with 17 colleges and schools, about 24,000 faculty and staff, and more than 50,000 students.

Career History
Director
Current

ReForm Biologics LLC develops formulation technologies for biotherapeutics molecules. It provides technologies that include Viscosity-reducing excipients, Stability-enhancing excipients, and Surfactant-replacing excipients. The company was founded by David S. Soane and Zachariah Jonasson and is headquartered in Cambridge, MA.

Co-Founder
1995 - Prior

Covance Biotechnology Services, Inc. develops pharmaceutical products. The company offers two microbiology laboratories, one for mycoplasma analysis, and a second for molecular biology. It provides services to biomolecules, including recombinant proteins, monoclonal antibodies, vaccines, blood products, and gene therapy products. The company was founded by Richard J. Hawkins, V. Bryan Lawlis, and John A. Scarlett in 1995 and is headquartered in Princeton, NJ.

President & Chief Executive Officer
2011 - 2017

Itero Biopharmaceuticals LLC is a private company headquartered in the United States that provides royalty payment services for licensing agreement. It was founded by V. Bryan Lawlis.

Boards & Committees
Director
2014 - Current

ReForm Biologics LLC develops formulation technologies for biotherapeutics molecules. It provides technologies that include Viscosity-reducing excipients, Stability-enhancing excipients, and Surfactant-replacing excipients. The company was founded by David S. Soane and Zachariah Jonasson and is headquartered in Cambridge, MA.

Chairman
1996 - 2001

Covance Biotechnology Services, Inc. develops pharmaceutical products. The company offers two microbiology laboratories, one for mycoplasma analysis, and a second for molecular biology. It provides services to biomolecules, including recombinant proteins, monoclonal antibodies, vaccines, blood products, and gene therapy products. The company was founded by Richard J. Hawkins, V. Bryan Lawlis, and John A. Scarlett in 1995 and is headquartered in Princeton, NJ.

Investments
Details Hidden

Itero Biopharmaceuticals, Inc. develops biopharmaceutical products for novel therapeutic proteins and antibodies. The firm focuses on the development and commercialization of protein therapeutics that offer significant clinical and commercial advantages over marketed alternatives. It provides recombinant follicle stimulating hormone for the treatment of female infertility. The company was founded in 2006 by Dr. V. Bryan Lawlis Jr., Dr. Darlene P. Horton and Roy Jerald Beers and is headquartered in Mountain View, CA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by V. Bryan Lawlis. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of V. Bryan Lawlis's profile does not indicate a business or promotional relationship of any kind between RelSci and V. Bryan Lawlis.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/v-bryan-lawlis-3306653
  • https://relationshipscience.com/person/v-bryan-lawlis-3306653